Visual parameters (totally 533 eyes)
| Visual parameters | Mean ± SD (min–max) |
|---|---|
| Uncorrected visual acuity (LogMAR) | 0.88 ± 0.64 (−0.1 to 2.3) |
| Best-corrected visual acuity† (LogMAR) | 0.40 ± 0.49 (−0.1 to 2.2) |
| Q-value | −0.92 ± 0.63 (−2.73 to 2.15) |
| Thinnest pachymetry (microns) | 459.39 ± 56.96 (282–589) |
| Mean keratometry (diopter) | 49.7 ± 6.64 (33.2–80.3) |
Demographic data
| Demographic data | Number of patients (percentage) n = 271 |
|---|---|
| Gender | |
| Male | 200 (73.8) |
| Female | 71 (26.2) |
| Affected eye | |
| Only right eye | 5 (1.9%) |
| Only left eye | 4 (1.5%) |
| Both eyes | 262 (97%) |
| Presenting symptoms | |
| Itching | 128 (47.2) |
| Known allergy† | 48 (17.7) |
| Blurred vision or frequently needed new glasses prescription | 237 (87.5%) |
| Previous visual rehabilitation | |
| Glasses | 141 (52) |
| Contact lens‡ | 27 (10) |
| Both glasses and contact lens | 16 (5.9) |
| None | 87 (32.1) |
Disease characteristics (totally 533 eyes in 271 patients)
| Disease characteristics | Number of eyes (percentage) n = 533 eyes |
|---|---|
| Amsler–Krumeich classification | |
| Stage 1 | 206 (38.6) |
| Stage 2 | 169 (31.7) |
| Stage 3 | 36 (6.8) |
| Stage 4 | 122 (22.9) |
| Signs | |
| Munson sign | 78 (14.8) |
| Rizutti sign | 37 (6.9) |
| Fleischer ring | 150 (28.1) |
| Vogt striae | 133 (25) |
| Corneal scarring | 46 (8.6) |
| Corneal staining | 41 (7.7) |
| Prominent corneal nerve | 15 (2.8) |
| Corneal topography | |
| Oval | 305 (57.2) |
| Nipple | 22 (4.1) |
| PMD-like | 28 (5.3) |
| Astigmatic | 178 (33.4) |
| Management (ICRS or CXL) | |
| ICRS | 105 (19.7) |
| CXL | 145 (27.2) |
| Both ICRS and CXL | 65 (12.2) |
| Corneal transplantation need† | |
| Unilateral | 12 (4.4) |
| Bilateral | 103 (38) |
| No need | 156 (57.6) |